World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 9 May 2016
Main ID:  NCT01929668
Date of registration: 23/08/2013
Prospective Registration: No
Primary sponsor: Kyungpook National University
Public title: Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Inactive UC Patients 2SCANI
Scientific title: Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Patients With Inactive Ulcerative Colitis; Randomized, Single Blind, Multicenter Study
Date of first enrolment: August 2013
Target sample size: 114
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT01929668
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Screening  
Phase:  N/A
Countries of recruitment
Korea, Republic of
Contacts
Name:     Eun Soo Kim, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Keimyung University School of Medicine
Key inclusion & exclusion criteria

Inclusion Criteria:

- age >18 years old

- ulcerative colitis patients without symptoms for at least 1 year

- ulcerative colitis patients who undergo colonoscopy for surveillance

Exclusion Criteria:

- subjects who had abdominal surgery

- pregnant or breast feeding



Age minimum: 18 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Ulcerative Colitis
Intervention(s)
Drug: Ascorbic Acid
Drug: polyethylene glycol
Primary Outcome(s)
Number of patients who are willing to use the same preparation method for the next colonoscopy. [Time Frame: day 1]
Secondary Outcome(s)
Number of patients who have ulcerative colitis symptom aggravation within 30 days after bowel preparation, measured by simple clinical colitis activity index (SCCAI). [Time Frame: within 30 days after bowel preparation for colonoscopy]
Secondary ID(s)
2013-07-036-002
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history